Upgrade to SI Premium - Free Trial

Incyte (INCY) PT Lowered to $94 at UBS

March 25, 2026 9:05 AM
UBS analyst Ashwani Verma lowered the price target on Incyte (NASDAQ: INCY) to $94.00 (from $104.00) while maintaining a Neutral ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change